Treatment of Back Pain Using Transcutaneous Magnetic Stimulation (TCMS)
NCT ID: NCT02421757
Last Updated: 2021-11-23
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2016-08-22
2017-06-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study will evaluate whether an experimental medical device (Fischell TCMS Pain Treatment Device) that emits pulses of a brief, intense magnetic field will relieve pain in the lower back. Transcutaneous Magnetic Stimulation (TCMS) is the name of this method of delivering magnetic pulses through the skin. TCMS has been approved by the FDA for peripheral nerve stimulation, treatment of migraine headaches and for depression but this type of device has not been studied scientifically for the treatment of back pain. No significant adverse reactions or side effects have been reported with the use of magnetic stimulation for headache treatment. Some patients who have migraine headaches have excellent pain relief with the magnetic treatment even if they do not get pain relief with medications. Other patients do not have headache relief with magnetic treatment. The current use of TCMS applied to the head requires special equipment and multiple treatment sessions. TCMS applied peripherally is easier to do, and may require fewer treatment sessions to achieve pain relief. Non-invasive treatment of pain would represent a significant advance in the field especially if its use both successfully treated pain and resulted in the reduction or elimination in the need for opioid medications.
The investigators do not know whether magnetic treatment will relieve back pain so the investigators will test this by applying a powerful electromagnet to the area of the back having pain. In some patients, the magnet will be turned on, but in other patients the magnet will not be turned on. Neither patients nor patient's treating doctor will know whether the magnet was turned on or not, although the study team will know which patients received treatment with magnetic pulses. The effect on pain will be recorded periodically for 2 days. If the patients' reported pain is reduced by having the magnet turned on compared to patients' who do not have the magnet turned on, then the magnet may have reduced the pain. Additional studies in patients will be needed to be sure that the magnet therapy is reducing low back pain.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transcutaneous Magnetic Stimulation
Transcutaneous Magnetic Stimulation
Fischell Transcutaneous Magnetic Stimulation Pain Treatment Device
Transcutaneous Magnetic Stimulation
Sham Device
Sham Device
Placebo
The placebo Transcutaneous device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fischell Transcutaneous Magnetic Stimulation Pain Treatment Device
Transcutaneous Magnetic Stimulation
Placebo
The placebo Transcutaneous device
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Prescription pharmacologic treatment is insufficient for treatment of pain
3. Pain duration of ≥ 6 months
4. Pain limits physical activity
5. Pain occurs daily
6. Chronic low back pain, with or without leg pain, associated with MRI or other imaging study consistent with lumbo-sacral spine disease with or without nerve compression
7. Pain intensity ≥ 5 at the time of enrollment a a self-reported pain score of ≥ 4 over the 7 preceding days.
Exclusion Criteria
2. Oral opiate dosing or type of opioid that has changed in past 12 months
3. Received intraspinal (e.g., epidural, intrathecal) medication in the past 6 months
4. Use of intravenous pain medication in the past 6 months
5. Active use of a transcutaneous electrical nerve stimulator (TENS) \[within 30 days\]
6. History of seizures
7. History of implanted medical device, cardiac pacemaker or implantable cardiac defibrillator, or other implant (Cochlear etc)
8. History of cardiac dysrhythmias
9. Member of vulnerable population
10. Current or potential legal action of disability claim related to back pain
11. Body Mass Index (BMI) \>35
12. Another pain condition that might confound results, including back pain above the waistline
13. Women of child-bearing potential
14. Inability to undergo study assessments or complete questionnaires independently
15. Metal objects in the body (i.e. Aneurysm clip, bullet fragment)
16. Active psychological co-morbidites (i.e. uncontrolled schizophrenia)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Maryland, Baltimore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter Rock
Professor of Anesthesiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Rock, MD
Role: PRINCIPAL_INVESTIGATOR
University of Maryland, Baltimore
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
La Toya Stubbs
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HP-00062233
Identifier Type: -
Identifier Source: org_study_id